Validation of the French Version of the Fremantle Back Awareness Questionnaire (FreBAQ) in Patients With Chronic Low Back Pain
FreBAQ
2 other identifiers
observational
150
1 country
1
Brief Summary
In patients with chronic low back pain, the Fremantle Back Awareness Questionnaire (FreBAQ) measures the duration and intensity of pain and functional limitations. The FreBAQ is a simple tool created to assess disturbances in the body representation of the back, and the only one existing in chronic low back pain. It is a 9-item self-questionnaire in which each item is measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)". It assesses neglect, perceived body image of the back, accuracy in proprioceptive perception of back movements. The psychometric properties of the FreBAQ in English, Japanese, Dutch, Turkish and German are validated and acceptable; however, they have never been studied in French and no validated version of this questionnaire in French exists. The study investigators hypothesize that the French version of the FreBAQ has good psychometric qualities, allowing it to be used in the French chronic low back pain population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedStudy Start
First participant enrolled
May 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2023
CompletedDecember 10, 2025
December 1, 2025
11 months
June 3, 2021
December 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Pre-test of French version of FreBAQ on 20 representative patients
9-item self-administered questionnaire newly translated into French using a standard translation-retro-translation system, each item measured on a 5-point Likert scale ranging from "Never (score of 0)" to "Always (score of 4)
Baseline
Secondary Outcomes (16)
FreBAQ score
Day 0
FreBAQ score in a subgroup of 50 subjects (35 patients and 15 controls)
Day 7
Evaluation of the internal consistency of the French version of the FreBAQ
Day 0
Evaluation of the unidimensionality of the French version of the FreBAQ
Day 0
Assessment of the reliability (test-retest) of the questionnaire in French
Day 7
- +11 more secondary outcomes
Study Arms (2)
Patients with low back pain
Controls
Interventions
Subjects will take the FreBAQ questionnaire at Day 0 and a subgroup of 35 controls and 15 patients will take the same questionnaire at Day 7
Eligibility Criteria
Patients with chronic low back pain defined as pain localized between the edge of the last lower ribs and the intergluteal groove (17) for more than 3 months followed in the Physical Medicine and Rehabilitation Department of the CHU of Nîmes and persons recruited among the members of the service and their entourage, as well as all patients coming for consultation in the service with no history of chronic low back pain and lumbar VAS \< 2 for more than 3 months.
You may qualify if:
- Subject with no history of chronic low back pain and with a lumbar VAS \<2 for more than 3 months.
- Patient with chronic low back pain: pain localized between the edge of the last lower ribs and the intergluteal groove (17) for more than 3 months.
- Patient with a lumbar VAS \> 2 for more than 3 months.
- Patient whose low back pain is of common origin (no underlying organic etiology).
- In case of lumbar-radicular pain, patient with a VAS (lumbar) \> VAS (leg)
- Patient who speaks and understands French
- Patient with no history of arthrodesis or lumbar disc prosthesis
- Subject affiliated or beneficiary of a health insurance plan.
- The patient must have given their free and informed consent and signed the consent form
You may not qualify if:
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- Patient pregnant, parturient or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nîmes
Nîmes, France
Related Publications (1)
Homs AF, Ragon A, Mura T, Terribile G, Alonso S, Dupeyron AF. Validation of the French version of the Fremantle Back Awareness Questionnaire in patients with chronic low back pain. Eur J Phys Rehabil Med. 2025 Apr;61(2):295-304. doi: 10.23736/S1973-9087.24.08412-0. Epub 2025 Mar 10.
PMID: 40066561RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexis Homs
CHU Nîmes
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2021
First Posted
June 18, 2021
Study Start
May 23, 2022
Primary Completion
April 28, 2023
Study Completion
April 28, 2023
Last Updated
December 10, 2025
Record last verified: 2025-12